Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;35(2):e15224.
doi: 10.1111/dth.15224. Epub 2021 Dec 4.

Juvenile xanthogranulomas in Asian children

Affiliations

Juvenile xanthogranulomas in Asian children

Lynette Wei Yi Wee et al. Dermatol Ther. 2022 Feb.

Abstract

Juvenile xanthogranuloma (JXG) is the most common non-Langerhans cell histiocytic disorder. It can rarely be associated with systemic involvement. There is a paucity of literature on JXG in Asian children. We aim to describe the epidemiology, clinical features, systemic associations, histological features and outcome of a cohort of Asian children with JXG, and review the literature on the condition. We retrospectively reviewed the demographic, clinical and histological data of patients less than 16 years of age, diagnosed with JXG at our tertiary pediatric hospital between January 2002 and April 2019. A total of 147 children with JXG were identified, with a slight male preponderance of 53.1%. The median age of the onset was 15.5 months, with 69.4% presenting before 2 years of age. There was no racial predilection. The most frequently involved site was the head and neck region (44.2%). The majority of patients (76.2%) presented with a solitary lesion. Spontaneous resolution was documented in 57.7% of our patients with mean duration to resolution of 18.8 months. The proportion and speed of resolution did not differ in children with single or multiple lesions. No ophthalmologic complications were detected in our study cohort. JXG in children is generally limited to the skin and is rarely associated with systemic involvement, including the eye. Unless clinically indicated, the results from our study does not support routine screening for juvenile myelomonocytic leukemia, eye or systemic complications, even in the setting of multiple cutaneous JXGs.

Keywords: JXG; Juvenile xanthogranuloma; histiocytosis.

PubMed Disclaimer

References

REFERENCES

    1. Hernandez-Martin A, Baselga E, Drolet BA, Esterly NB. Juvenile xanthogranuloma. J Am Acad Dermatol. 1997;36(3 Pt 1):355-367. quiz 368-9.
    1. Gianotti F, Caputo R. Histiocytic syndromes: a review. J Am Acad Dermatol. 1985;13(3):383-404.
    1. Harmon CM, Brown N. Langerhans cell Histiocytosis: a Clinicopathologic review and molecular Pathogenetic update. Arch Pathol Lab Med. 2015;139(10):1211-1214.
    1. So N, Liu R, Hogeling M. Juvenile xanthogranulomas: examining single, multiple, and extracutaneous presentations. Pediatr Dermatol. 2020;37(4):637-644.
    1. Emile JF, Charlotte F, Chassagne-Clement C, et al. Histiocytoses: general classification and molecular criteria. Presse Med. 2017;46(1):46-54.

LinkOut - more resources